| October 17, 2022 |
Fujirebio obtains approval to a SARS-CoV-2 antigen rapid test for use as a general test drug[PDF:172KB] |
| April 1, 2022 |
Launch of Comprehensive Service for COVID-19 Control Through Wastewater Testing, Hygiene and Sanitation Management, and Clinical Laboratory Testing[PDF:178KB] |
| February 18, 2022 |
Launch of “COVID-19 & IVD Testing Program” Service[PDF:158KB] |
| January 13, 2022 |
Launch of WithInfo, App for Assistance in Operation of Rapid Testing Kits ESPLINE® SARS-CoV-2&Flu A+B and ESPLINE® SARS-CoV-2[PDF:135KB] |
| August 13, 2021 |
Approval of Manufacturing and Marketing Authorization for ESPLINE® SARS-CoV-2 & Flu A+B, the Rapid Assay for Simultaneous Detection of SARS CoV-2 and Influenza Viruses[PDF:181KB] |
| July 30, 2021 |
Launch of the Reagent for Research for the Detection of IgG Antibodies Targeting the SARS-CoV-2 N-protein[PDF:224KB] |
| June 1, 2021 |
Initiatives in Workstyle Reform amid COVID-19 Pandemic[PDF:110KB] |
| May 27, 2021 |
H.U. Group and MICIN Commence Verification of Online Outpatient Clinic for Patients with Fever[PDF:186KB] |
| April 23, 2021 |
Sale of Research Assay Reagents and Undertaking of Research Tests for Detecting IgG Antibodies for the Novel Coronavirus's Spike Protein[PDF:240KB] |
| March 15, 2021 |
First Practical Implementation in Japan of Data Integration Between CommonPass and PCR Tests[PDF:399KB] |
| March 5, 2021 |
Sale of Research Assay Reagents and Undertaking of Research Tests for IgM Antibody of Novel Coronavirus[PDF:92KB] |
| March 2, 2021 |
Practical Implementation of a Genome Analysis Method Using Next- Generation Sequencers[PDF:94KB] |
| February 17, 2021 |
SRL Undertakes Screening Tests for Novel Coronavirus Variants and Genome Analysis[PDF:75KB] |
| January 28, 2021 |
Winner of the Special Committee Award at the 9th Technology Management and Innovation Awards[PDF:98KB] |
| January 19, 2021 |
Approval and Launch of Influenza Virus Antigen Reagent for Use with Large Instruments from LUMIPULSE® Series[PDF:147KB] |
| January 13, 2021 |
Commencement of Operation of New Factory for ESPLINE® Rapid Diagnostic Tests[PDF:99KB] |
| December 22, 2020 |
Application to the U.S. FDA for EUA Approval of High-sensitive Antigen Test for SARS-CoV-2[PDF:28KB] |
| December 18, 2020 |
Nihon Stery Partners with ANA to Further Strengthen Its COVID-19 Safety Measures[PDF:32KB] |
| December 22, 2020 |
Application to the U.S. FDA for EUA Approval of High-sensitive Antigen Test for SARS-CoV-2[PDF:28KB] |
| June 10, 2020 |
The new factory for the novel coronavirus (SARS-CoV-2) antigen test kit[PDF:107KB] |
| May 15, 2021 |
Authorization to manufacture and market a rapid diagnostic test kit for the Novel Coronavirus (SARS-CoV-2) antigen[PDF:191KB] |
| January 31, 2020 |
Necessary Supplies to Wuhan, China to Combat the Coronavirus Outbreak[PDF:98KB] |
